Clinical Advancement in Aortic Valve Stenosis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 25 June 2024 | Viewed by 2637

Special Issue Editors


E-Mail Website
Guest Editor
Translational Cardiovascular Research Group, Department of Cardiology, Milton Keynes University Hospital NHS Trust, Milton Keynes, UK
Interests: integrated cardiovascular imaging; cardiac CT; echocardiography; CMR; coronary artery disease; ischemia; AI in cardiac image acquisition and analysis

E-Mail Website
Guest Editor
1. Heart Division, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK
2. Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, UK
Interests: imaging of coronary heart disease; risk assessment; ventricular assist devices; heart failure; aortic valve disease; heart and lung transplantation

Special Issue Information

Dear Colleagues,

The understanding of the impact of aortic valve stenosis on outcome irrespective of its severity has changed since the advent of populational databases on AS since the landmark publication by Ross and Braunwald in 1968. The pathophysiology of AS, like that of atherosclerosis, constitutes an exciting field for research. The available interventions once AS reaches a severe grade is also evolving from open-heart to keyhole surgical techniques. The timing of intervention and association with survival is a matter of active debate. This Special Issue on AS is dedicated to review evidence and helps in understanding the best diagnostic and therapeutic strategies (including echocardiography, cardiac CT, cardiac MRI, risk factor management, and novel anti-inflammatory agents to minimally invasive surgery). 

Prof. Dr. Attila Kardos
Dr. Tarun Kumar Mittal
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aortic stenosis
  • diagnostic strategies
  • therapeutic options
  • timing of intervention
  • minimally invasive surgery

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

11 pages, 2144 KiB  
Article
Prognostic Relevance of Global Myocardial Work Index in Patients with Moderate Aortic Valve Stenosis
by Joscha Kandels, Michael Metze, Andreas Hagendorff and Stephan Stöbe
J. Clin. Med. 2023, 12(24), 7694; https://doi.org/10.3390/jcm12247694 - 14 Dec 2023
Viewed by 651
Abstract
Background: A reduced global myocardial work index (GWI) ≤ 1951 mmHg% is associated with increased mortality in patients with severe aortic valve stenosis (AS). However, parameters predicting the outcome in patients with moderate AS are limited. Therefore, the aim of this study was [...] Read more.
Background: A reduced global myocardial work index (GWI) ≤ 1951 mmHg% is associated with increased mortality in patients with severe aortic valve stenosis (AS). However, parameters predicting the outcome in patients with moderate AS are limited. Therefore, the aim of this study was to evaluate the prognostic value of the GWI in patients with moderate AS. Methods and Results: In this prospective study, 103 patients with moderate AS (mean age 72 ± 10 years; male: 69%) underwent standardized transthoracic echocardiography. The primary endpoint was survival without an aortic valve replacement (AVR). After a median follow-up of 30 ± 5 months, 37 patients (36%) were referred for an AVR. Survival without an AVR was 96% at 12 months and 80% at 30 months (>1951 mmHg%) versus 96% and 68% (≤1951 mmHg%). A GWI ≤ 1951 mmHg% did not predict the need for an AVR (hazard ratio 1.31 (95% CI, 0.63–2.72), p = 0.49). Furthermore, there was no significant correlation between the mean GWI (1644 ± 448 mmHg%) and mean aortic valve pressure gradient (24.2 mmHg ± 6.2, p = 0.615) or effective aortic orifice area (1.24 cm2 ± 0.11, p = 0.678). There was no difference between the AVR and non-AVR groups in the occurrence of clinical symptoms. Conclusion: In contrast to patients with severe AS, a GWI ≤ 1951 mmHg% did not predict the need for an AVR. Further research is needed to improve the risk stratification in patients with moderate AS. Full article
(This article belongs to the Special Issue Clinical Advancement in Aortic Valve Stenosis)
Show Figures

Figure 1

10 pages, 1006 KiB  
Article
Sex Differences in Clinical Outcomes after Aortic Valve Intervention for Isolated Severe Aortic Stenosis
by Teresa Sevilla, Noemí Ramos, Manuel Carnero, Ignacio J. Amat-Santos, Manuel Carrasco-Moraleja, Ana Revilla, Isidre Vilacosta and J. Alberto San Román
J. Clin. Med. 2023, 12(22), 7025; https://doi.org/10.3390/jcm12227025 - 10 Nov 2023
Cited by 1 | Viewed by 639
Abstract
There are known pathophysiologic and clinical differences according to sex in patients with aortic stenosis (AS). To evaluate if these differences persist after valve replacement, we conducted an observational study including 451 patients with symptomatic AS who survived aortic valve intervention (AVI) in [...] Read more.
There are known pathophysiologic and clinical differences according to sex in patients with aortic stenosis (AS). To evaluate if these differences persist after valve replacement, we conducted an observational study including 451 patients with symptomatic AS who survived aortic valve intervention (AVI) in two centers. Clinical data and mortality were evaluated at a mean follow-up of 5 years. 56% of patients were women. At baseline, women were older (80.6 vs. 78 years, p = 0.013), presented higher mean gradient (48 vs. 45 mmHg, p = 0.023), lower aortic valve area (0.70 vs. 0.74 cm2, p = 0.002) and higher systolic pulmonary artery pressure (36 vs. 33 mmHg, p = 0.016). They underwent percutaneous aortic valve replacement more frequently than men (47 vs. 35.9%, p = 0.017). At 5 years follow-up, women required more admissions due to heart failure (23 vs. 9%, p = 0.046) but they did not present higher cardiovascular nor overall mortality (27.7% vs. 29.8%, p = 0.741; 11.1 vs. 10.1%, p = 0.619, respectively). Female sex was an independent predictor of heart failure hospitalization at follow-up (HR 95% 1.16–4.22, p = 0.016). Women undergo AVI at a more advanced stage than men, resulting in a higher frequency of readmissions due to heart failure during the follow-up period, but not in higher mortality. Full article
(This article belongs to the Special Issue Clinical Advancement in Aortic Valve Stenosis)
Show Figures

Figure 1

Review

Jump to: Research

16 pages, 1262 KiB  
Review
Influence of Aortic Valve Stenosis and Wall Shear Stress on Platelets Function
by Paweł Bańka, Maciej Wybraniec, Tomasz Bochenek, Bartosz Gruchlik, Aleksandra Burchacka, Andrzej Swinarew and Katarzyna Mizia-Stec
J. Clin. Med. 2023, 12(19), 6301; https://doi.org/10.3390/jcm12196301 - 29 Sep 2023
Viewed by 1026
Abstract
Aortic valve stenosis (AS) is a common heart valve disease in the elderly population, and its pathogenesis remains an interesting area of research. The degeneration of the aortic valve leaflets gradually progresses to valve sclerosis. The advanced phase is marked by the presence [...] Read more.
Aortic valve stenosis (AS) is a common heart valve disease in the elderly population, and its pathogenesis remains an interesting area of research. The degeneration of the aortic valve leaflets gradually progresses to valve sclerosis. The advanced phase is marked by the presence of extracellular fibrosis and calcification. Turbulent, accelerated blood flow generated by the stenotic valve causes excessive damage to the aortic wall. Elevated shear stress due to AS leads to the degradation of high-molecular weight multimers of von Willebrand factor, which may involve bleeding in the mucosal tissues. Conversely, elevated shear stress has been associated with the release of thrombin and the activation of platelets, even in individuals with acquired von Willebrand syndrome. Moreover, turbulent blood flow in the aorta may activate the endothelium and promote platelet adhesion and activation on the aortic valve surface. Platelets release a wide range of mediators, including lysophosphatidic acid, which have pro-osteogenic effects in AS. All of these interactions result in blood coagulation, fibrinolysis, and the hemostatic process. This review summarizes the current knowledge on high shear stress-induced hemostatic disorders, the influence of AS on platelets and antiplatelet therapy. Full article
(This article belongs to the Special Issue Clinical Advancement in Aortic Valve Stenosis)
Show Figures

Figure 1

Back to TopTop